Billy Don Burns made headlines last year after he tried to take his own life in a drug-fueled rage. There’s good news to ...
The treatment, a type of immunotherapy which harnesses the body’s immune system to fight cancer, was found to shrink tumours ...
New prostate cancer drug showing ‘remarkable’ results during clinical trial - The new drug, known as VIR-5500, uses a ...
Reopened Allentown facility expands addiction treatment capacity and launches specialized reentry track Strong ...
MyTwinTiers.com on MSN
Towanda woman resentenced after violating original sentence
BRADFORD COUNTY, Pa. (WETM) — A Towanda woman was resentenced to time in state prison for failing to comply with her original ...
A new CRISPR-based tool that is directly used on patients' cancer cells can identify genes and regulatory elements driving ...
The Food and Drug Administration aims to evaluate treatments for rare diseases based on plausible evidence that they would ...
Daily Times on MSN
Philly woman gets 5-10 years for fatal drug delivery to Ridley man
A Philadelphia woman was sentenced to 5-10 years in a state prison for delivering a fatal dose of fentanyl to a Ridley man in December 2024. Chelyn M. Beck, 44, of the 300 block of North 62nd Street, ...
Federal prosecutors said Friday they won’t appeal a judge’s ruling that bars them from seeking the death penalty against ...
Officials laid out a proposal to spur development of customized treatments for patients with hard-to-treat diseases, ...
Montelukast is a leukotriene receptor antagonist approved for the prophylactic and chronic treatment of asthma and the relief of allergic rhinitis.
Eli Lilly has rolled out a multi-dose KwikPen version of tirzepatide, marketed as Zepbound, for chronic weight management—signaling a packaging update for one of the obesity market’s fastest-expanding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results